2Januzzijl JR,Camargo CA,Anwaruddin S,et al.The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study[J].Am J Cardiol,2005;95(8):948-54.
3The Criteria Committee of New York Heart.Association 1994 revision to classification of functional capacity and objective assessment of patients with disease of the heart[J].Circulation,1994;90(7):644-5.
5Vanderheyden M,Bartunek J,Filippatos G,et al.Cardiovascular disease in patients with chronic renal impairment:role of natriuretic peptides[J].Congest Heart Fail,2008;14(1):38-42.
二级参考文献10
1Collins SP, Ronan-Bentle S, Storrow AB. Diagnostic and prognostic usefulness of natriuretic peptides in emergency department patients with dyspnea. Ann Emerg Med ,2003,41:532-545.
2Shapiro BP, Chen HH, Burnett JC Jr, et al. Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure. Mayo Clin Proc, 2003,78:481-486.
3Tjeerdsma G, de Boer RA, Boomsma F, et al. Rapid bedside measurement of brain natriuretie peptide in patients with chronic heart failure. Int J Cardiol,2002,86 : 143-149.
4Latini R, Masson S, de Angelis N, et al. Role of brain natriuretic peptide in the diagnosis and management of heart failure: current concepts. J Card Fail, 2002,8:288-299.
5Logeart D. Ultra-rapid measurement of brain natriuretic peptide.Arch Mal Coeur Vaiss, 2002,95:185-188.
6Peacock WF 4th. The B-type natriuretie peptide assay : a rapid test for heart failure. Cleve Clin J Med,2002 ,69 :243-251.
7Valli N, Georges A, Corcuff JB, et al. Assessment of brain natriuretic peptide in patients with suspected heart failure :comparison with radionuclide ventriculography data. Clin Chim Acta,2001,306 : 19-26.
8Nicholls MG, Lainchbury JG, Richards AM, et al. Brain natriuretic peptide-guided therapy for heart failure. Ann Med, 2001,33 : 422-427.
9Sodian R, Ixcbe M, Schmitt C, et al. Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems. J Am CoN Cardiol, 2001,38 : 1942-1949.
10Richards AM, Nicholls MG, Espiner EA, et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation ,2003,107:2786-2792.
5The Criteria Committee of New York Heart Association. AHA medical/ 1994 revisions to classification of functional capacity and objective as- sessment of patients with disease of the heart [ J ]. Circulation, 1994 , 90 ( 1 ) :644-5.
6Wieczorek SJ, WU AH, Christenson R,et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure : a multicenter evaluation [ J ]. Am Heart J,2002 , 144 ( 5 ) : 834 -39.
7Vanderheyden M, Bartunek J, Filippatos G, et al. Cardiovascular disease in patients with chronic renal impairment: role of natriuretic peptides [J]. Congest Heart Fail,2008 ,14(4-1 ) :38-42.
8Aurigemma GP, Zile MR, Gaasch WH. Contractile behavior of the left ventricle in diastolic heart failure: with emphasis on regional systolic function [ J ]. Circulation,2006 , 113 ( 2 ) :296-340.
9Palazzuoli A, Gallotta M, Quatrini I, et al. Natriuretic peptides (BNP and proBNP) : measurement and NT-relevanee in heart failure [J]. Vasc Health Risk Manag, 2010 , 6 : 411 -8.
